Petros Pharmaceuticals, Inc. announces that Mohit Khera, M.D., M.B.A., M.P.H. has joined the company's steering committee to develop expanded patient access initiatives for STENDRA® (avanafil) product, an oral medication used in the treatment of erectile dysfunction (ED). Mohit Khera, M.D., M.B.A., M.P.H., specializes in male infertility, male and female sexual dysfunction, and testosterone replacement therapy. Dr. Khera has dedicated his clinical and research efforts to three main areas: testosterone, erectile dysfunction, and Peyronie's disease. Soon after completing my fellowship he started the Laboratory for Andrology Research. His laboratory focuses on basic science research on testosterone and its effects on the prostate, stem cells to treat erectile dysfunction, the effects of finasteride on sexual function, and genetic markers of hypogonadism. In his laboratory he has had the opportunity to train many residents and research fellows. In addition to his basic science research, he has initiated numerous FDA approved clinical trials. His basic science and clinic experiences have allowed him to thus far give over 250 lectures at scientific meetings, publish over 100 articles in peer reviewed journals, complete 15 book chapters, and edit and write two books all in the field of sexual medicine. Dr. Khera freely shares his time and knowledge with the general public. He has been voted one of Houston's Best Doctors numerous times by Health and Sport Fitness Magazineand by Houstonia Magazine and is a frequent guest on such TV programs as Fox News' "Ask the Doctor." He also writes a blog on Men's Health for the Houston Chronicle Newspaper.